{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P43405",
      "entity_text" : "Syk",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P43405",
      "entity_text" : "Syk",
      "features" : [ {
        "position" : "Y346",
        "modification_type" : "phosphorylation",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR XREF_BIBR Furthermore, we revealed that the target of TULA-2 is Syk Y346 (Y352 in human), the phosphorylation of which, in concert with Y342 (Y348 in human), acts to prevent Syk from adopting an autoinhibitory conformation.",
  "reading_complete" : "2020-08-02T13:22:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:21:06Z",
  "trigger" : "prevent",
  "evidence" : [ "Syk Y346 (Y352 in human), the phosphorylation of which, in concert with Y342 (Y348 in human), acts to prevent Syk" ],
  "pmc_id" : "6524918",
  "score" : 0
}